Several nomograms exist for ordering palladium-103 seeds for permanent prostate seed implants (PSI). Excess seeds from PSIs pose additional radiation safety risks and increase the cost of care. This study compared five nomograms to clinical data from dynamic modified-peripheral intraoperative PSI to determine (a) the cause of excess seeds and (b) the optimal nomogram for our institution. Pre-and intraoperative patient data were collected for monotherapy PSIs and compiled into a clinical database. All patients were prescribed 125 Gy with dose coverage of D90% = 100% to the planning target volume (PTV) using 103 Pd seeds with mean air-kerma strength ization factor was applied to the number of seeds used intraoperatively to meet all four conditions. Four published nomograms, an in-house nomogram, and the normalized number of implanted seeds for each patient were plotted against intraoperative prostate volume. Of the 226 patients, 223 had excess seeds at the completion of their PSI. On average, 25.7 ± 9.9% of ordered seeds were not implanted. Excess seeds were separated into two categories, accounted-for excess, determined by the four normalization factors, and residual excess, assumed to be due to overordering.
2.A | Excess seeds
The clinical database was used to determine the number of excess seeds for each patient. The number of excess seeds (N XS ) is defined in eq. (1) .
N XS ¼ ðnumber of seeds orderedÞ
À ðnumber of seeds used intra À operativelyÞ
The total number of excess seeds can be separated into two categories, accounted-for excess (A XS ) and residual excess (R XS ). The quantity A XS is equal to the sum of the number of excess seeds remaining after an implant (n) which can be attributed to a specific reason (i) [eq. (2) ]. The value of n i can be positive or negative.
Excess seeds that could not be attributed to a specific cause were considered "residual." The quantity R XS is equal to the number of excess seeds less the number of accounted-for excess seeds [eq. (3)].
We identified four potential causes of excess seeds which are summarized in Table 1 value is converted into number of seeds using vendor specified air-kerma strength per seed, it is not necessarily an integer. For simplicity in ordering and to insure enough seeds were present for the procedure, nomogram results were frequently rounded up to the nearest multiple of five. If more seeds were ordered than indicated by the nomogram, the result is a known excess compared to the nomogram, i.e., n order . If fewer seeds were ordered than indicated by the nomogram, the result is a known seed deficit, i.e., n order .
T A B L E 1 Variables which contribute to deviations between the expected number of seeds used intraoperatively and actual number of seeds used intraoperatively.
Reasons for excess seeds Description
Number of excess seeds due to reason (i) All patients were prescribed 125 Gy with dose coverage of D90% = 100% to the planning target volume (PTV). If the intraoperative D90% was less than 100%, i.e., a "cold implant," then not enough seeds were used during the implant resulting in a known seed excess at the end of the procedure, i.e., n D90% . If the intraoperative D90% was greater than 100%, more seeds were used than anticipated which lowered the number of excess seeds at the end of the procedure, i.e., n D90% . If the mean air-kerma strength (S K ) for a batch of seeds was greater than 2 U per seed, fewer seeds were required to meet the prescription dose of D90% = 100% to the PTV resulting in a known seed excess, i.e., n U . If the mean air-kerma strength (S K ) for a batch of seeds was less than 2 U per seed, a greater number of seeds were required to meet the prescription dose of D90% = 100% to the PTV resulting in a known seed deficit,
i.e., n U .
2.B | Clinical data normalization parameters
Once the cause of excess seeds was determined, the number of seeds used intraoperatively per patient was linearly normalized such that S K ¼ 2 U and the intraoperative D90% was equal to 100%. The normalized number of 103 Pd seeds vs intraoperative prostate volume for each patient was plotted against intraoperative prostate volume and the upper 99.9% confidence interval of the patient data was generated.
| RESULTS
Between 2010 and 2015, our institution treated 251 patients with TIPPB using 103 Pd to a dose of 125 Gy. Pre-, intra-, and postoperative assessments were measured and compiled into a clinical database. For this study, exclusion criteria were: (a) an absolute difference greater than 20% between the intra-and postoperative D90% to the PTV (n = 20), (b) postoperative data were not available (n = 2), and (c) the combined modality therapy (external beam radiation therapy and TIPPB) nomogram was used to order seeds (n = 3).
This left n = 226 patients in the study. Table 2 lists patient-specific assessments for three sample patients. Table 3 shows the calculation performed using the assessments in Table 2 to determine n i and subsequently N XS , A XS , and R XS . A negative sign in Table 3 indicates that variable contributed positively toward R XS , that is, there should have been more seeds at the end of the procedure due to that specific variable.
3.A | Excess seeds
Of the 226 prostate seed implants, 98.6% (n = 223) had excess Percentage of ordered seeds which were wasted = # of excess seeds # of seeds ordered Â 100%
We found that none of the four parameters identified above contributed substantially to seed excess. In the cases where the intraoperative volume was greater than preoperative volume (53% of implants, n = 117), more seeds were used than anticipated to accommodate the larger prostate. In the cases where the implant had a D90% > 100%, i.e., a "hot implant" (72% of implants, n = 159), more seeds were used than anticipated which should have contributed towards the final number of excess seeds. In the cases where the mean air-kerma strength was greater than 2 U (43% of implants, n = 98), more seeds were used than anticipated which should have contributed towards the number of excess seeds. The value of n i was on average negative for each "i." The consequence of n i \0 means the number of residual-excess seeds was on average greater than the physical number of excess seeds. On average, 30.7 ± 7.1% of ordered seeds were R XS . Table 4 shows the average N XS , R XS , and n i .
| Nomogram
The clinical data, after being normalized such that S K ¼ 2U and D90% = 100%, was compared to five nomograms: AAPM TG-64, . The disparity between nomograms could be attributed to their variety in formulation. The T A B L E 3 Determination of residual-excess (R XS ) seeds for patients A, B, and C from Table 2 .
Determination of R XS
Derivation using columns from N XS n vol n order n D90% n U R XS n i AE 1r i 29.2 ± 13.2 −0.6 ± 13.9 −1.1 ± 3.5 −3.4 ± 6.9 −0.1 ± 1.7 34.4 ± 9.3 nomogram by Wang 7 is a theoretical derivation where the prostate is modeled as a sphere and radioactivity is considered to be in continuous form. The Anderson nomogram was generated from matched peripheral dose of 13 103 Pd implants and 64 125 I implants evaluated as if 103 Pd had been used. 6 Our institution uses a modified peripheral loading technique, 3D
transrectal ultrasound, and dynamic intraoperative delivery. 
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